Jounce Therapeutics, Inc. Pre-Tax Profit Margin 2017-2022 | JNCE
Jounce Therapeutics, Inc. pre-tax profit margin from 2017 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2021-12-31 | $0.03B | $-0.09B | -337.04% |
| 2019-12-31 | $0.15B | $0.06B | 38.78% |
| 2019-09-30 | $0.17B | $0.08B | 46.71% |
| 2019-06-30 | $0.06B | $-0.03B | -46.03% |
| 2019-03-31 | $0.07B | $-0.03B | -41.54% |
| 2018-12-31 | $0.07B | $-0.03B | -43.08% |
| 2018-09-30 | $0.06B | $-0.04B | -63.79% |
| 2018-06-30 | $0.06B | $-0.03B | -54.10% |
| 2018-03-31 | $0.06B | $-0.03B | -48.39% |
| 2017-12-31 | $0.07B | $-0.02B | -23.94% |
| 2017-09-30 | $0.08B | $-0.00B | -1.28% |
| 2017-06-30 | $0.08B | $0.01B | 9.09% |
